Phospholane, 1,1'-(1,2-ethanediyl)bis[2,5-dimethyl-, (2S,2'S,5S,5'S)-, 98%, 250mg

3-(chloromethyl)-5-isobutyl-1,2,4-oxadiazole, 95.0%, 5g

(S)-3-IODO-TETRAHYDROFURAN, 95.0%, 1g

tert-butyl ((1R,3S)-3-acetylcyclopentyl)carbamate compound with tert-butyl ((1S,3R)-3-acetylcyclopentyl)carbamate, 97%, 250mg

6-BOC-2-AMINO-6-AZASPIRO[3.5]NONANE, 95.0%, 100mg

2-(Dicyclohexylphosphino)-2',4',6'-tri-isopropyl-1,1'-biphenyl, 98.0%, 100g

3-Chloro-5-(trifluoromethyl)pyridine-2-thiol, 85.0%, 250mg

1-[2-(dimethylamino)ethyl]-5-oxopyrrolidine-3-carboxylic acid, 95.0%, 10g

Trimethylsilanol, 94.0%, 1g

4,6-Dichloro-7-azaindole, 95.0%, 25g

8-chloro-2-phenylquinoline-4-carboxylic acid, 95.0%, 250mg

Solución estándar de Osmio ICP, ROTI®Star, 30 ml, envase de vidrio

Clorhidrato de L-γ-azidohomalanina, mínimo 98 %, 100 mg, envase de plástico.